THE FOLLOWING MEDICAL AND SCIENTIFIC MATERIAL IS FOR CONSUMER INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY-- UNDER SECTION 5 OF DSHEA.

DISCLAIMER: NOTHING IN THIS WEBSITE IS INTENDED AS, OR SHOULD BE CONSTRUED AS, MEDICAL ADVICE. CONSUMERS SHOULD CONSULT WITH THEIR OWN HEALTH CARE PRACTITIONERS FOR INDIVIDUAL, MEDICAL RECOMMENDATIONS. THE INFORMATION IN THIS WEBSITE CONCERNS DIETARY SUPPLEMENTS, OVER-THE-COUNTER PRODUCTS THAT ARE NOT DRUGS. OUR DIETARY SUPPLEMENT PRODUCTS ARE NOT INTENDED FOR USE AS A MEANS TO CURE, TREAT, PREVENT, DIAGNOSE, OR MITIGATE ANY DISEASE OR OTHER MEDICAL OR ABNORMAL CONDITION.

You are about to view a presentation on the probiotic strains L. reuteri RC-14® and L. rhamnosus GR-1™ by Dr. Gregor Reid, Ph. D. Dr. Reid is a renowned probiotic researcher and the world's leading expert in using clinically-documented probiotics to address women's health concerns. Dr. Gregor Reid, along with his colleague at UREX Biotech, Dr. Andrew Bruce, have been investigating the use of probiotic bacteria to address women's health issues for over twenty years. In the 1980's, their discovery of two Lactobacillus strains, specifically L. rhamnosus GR-1™ and L. reuteri RC-14®, has since led to over 20 published clinical trials and over 200 peer-reviewed publications that have documented the various beneficial effects of these two probiotic strains when taken as an oral dietary supplement.  The health benefits include improved vaginal and urinary tract health, as well as restoration of a normal vaginal microflora profile in women who are experiencing bacterial vaginosis.

This presentation includes clinical trial results as to treatment of infections. JFI is including the full presentation in the interest of accuracy and completeness on this scientific research. However, again, Fem-Doliphus is not intended for, marketed for, or sold as a treatment for any infection or abnormal condition.

To See The Presentation, Click Here